A systematic review of hepatitis E virus infection in children

Clinical Infectious Diseases

Volumn 59, Issue 5, 2014, Pages 689-697

  Verghese, Valsan Philip ^a   Robinson, Joan L ^b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

Hepatitis E; Pediatric

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS E VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PEGINTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS ANTIBODY;

AGE; CHILD; CLINICAL FEATURE; DISEASE CARRIER; DISEASE TRANSMISSION; GRAFT RECIPIENT; HEPATITIS A; HEPATITIS E; HEPATITIS E VIRUS; HISTOPATHOLOGY; HUMAN; JAUNDICE; NEWBORN INFECTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; SYSTEMATIC REVIEW; VERTICAL TRANSMISSION; VIRUS INFECTIVITY; ADOLESCENT; BLOOD; EGYPT; IMMUNOLOGY; INDIA; INFANT; NEWBORN; PATHOGENICITY; PRESCHOOL CHILD; TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; EGYPT; HEPATITIS A; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INDIA; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; SEROEPIDEMIOLOGIC STUDIES; TRANSPLANT RECIPIENTS; YOUNG ADULT;

EID: 84907415396     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu371     Document Type: Review

References (96)

1. Mushahwar IK. Hepatitis E virus: molecular virology, clinical manifestations, diagnosis, transmission, epidemiology, prevention. J Med Virol 2008; 80:646-58. (Pubitemid 351358563)
2. Aggarwal R, Jameel S. Hepatitis E. Hepatology 2011; 54:2218-26.
3. Arora NK, Panda SK, Nanda SK, et al. Hepatitis E infection: study of an outbreak. J Gastroenterol Hepatol 1999; 14:572-7.
4. Guthmann JP, Klovstad H, Boccia D, et al. A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis 2006; 42:1685-91. (Pubitemid 43839431)
5. Aggarwal R. The global prevalence of hepatitis E virus infection and susceptibility: a systematic review. Geneva, Switzerland: World Health Organization, 2010. Available at: http://whqlibdoc.who.int/hq2010/WHO-IVB-10.14- eng.pdf. Accessed 3 June 2014.
6. Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E in Pune, India, 1982 and 1992. J Infect Dis 1995; 171:447-50.
7. Khurroo MS. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res 2011; 161:3-14.
8. Labrique AB, Shikdar SS, Krain LJ, et al. Hepatitis E: a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012; 18:1401-4.
9. Hooks SB, Billings CJ, Herrera JL. Hepatitis E virus infection. Pract Gastroenterol 2009; 33:11-7.
10. Colson P, Coze C, Galian P, Mireille H, De Micco P, Tamalet C. Transfusion- associated hepatitis E, France. Emerg Infect Dis 2007; 13:648-9.
11. Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Mingle JA, Nartey ET. Unexpected elevated alanine aminotransferase, aspartate aminotransferase levels and hepatitis E virus infection among persons who work with pigs in Accra, Ghana. Virol J 2010; 7:336.
12. Meng X-J. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011; 161:23-30.
13. Dell'Amico MC, Cavallo A, Gonzales JL, et al. Hepatitis E virus genotype 3 in humans and swine, Bolivia. Emerg Infect Dis 2011; 17:1488-90.
14. Wichmann O, Schimanski S, Koch J, et al. Phylogenetic and case control study on hepatitis E virus infection in Germany. J Infect Dis 2008; 198:1732-41.
15. Colson P, Borentain P, Queyriaux B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202:825-34.
16. Masuda J-I, Yano K, Tamada Y, et al. Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol Res 2005; 31:178-83. (Pubitemid 40542903)
17. Kuno A, Ido K, Isoda N, et al. Sporadic acute hepatitis E of a 47-year old man whose pet cat was positive for antibody to hepatitis E virus. Hepatol Res 2003; 26:237-42. (Pubitemid 36927199)
18. Lee S-D, Wang Y-J, Lu R-H, Chan C-Y, Lo K-J, Moeckli R. Seroprevalence of antibody to hepatitis E virus among Chinese subjects in Taiwan. Hepatol 1994; 19:866-70. (Pubitemid 24109346)
19. Lin D-B, Lin J-B, Chen S-C, Yang C-C, Chen W-K, Chen C-J. Seroepidemiology of hepatitis E virus infection among preschool children in Taiwan. J Med Virol 2004; 74:414-8. (Pubitemid 39281639)
20. Arankalle VA, Chadha MS, Chitambar SD, Walimbe AM, Chobe LP, Gandhe SS. Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98). J Viral Hepat 2001; 8:293-303. (Pubitemid 32673742)
21. Vivek R, Chandy GM, Brown DW, Kang G. Seroprevalence of IgG antibodies to hepatitis E in urban and rural southern India. Trans Royal Soc Trop Med Hyg 2010; 104:307-8.
22. Amarapurkar D, Agal S, Baijal R, et al. Epidemiology of hepatitis E virus infection in western India. Hepat Month 2008; 8:258-62.
23. Clayson ET, Shrestha MP, Vaughn DW, et al. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J Infect Dis 1997; 176:763-6. (Pubitemid 27360546)
24. Hau CH, Hien TT, Tien NTK, et al. Prevalence of enteric hepatitis A and E viruses in the Mekong River Delta region of Vietnam. Am J Trop Med Hyg 1999; 60:277-80. (Pubitemid 29107117)
25. Toole MJ, Claridge F, Anderson DA, et al. Hepatitis E virus infection as a marker for contaminated community drinking water sources in Tibetan villages. Am J Trop Med Hyg 2006; 74:250-4. (Pubitemid 46774336)
26. Labrique AB, Zaman K, Hossain Z, et al. Population seroprevalence of hepatitis E virus antibodies in rural Bangladesh. Am J Trop Med Hyg 2009; 81:875-81.
27. Saffar MJ, Farhadi R, Ajami A, Khalilian AR, Babamahmodi F, Saffar H. Seroepidemiology of hepatitis E virus infection in 2-25 year-olds in Sari District, Islamic Republic of Iran. Eastern Medit Health J 2009; 15:136-42.
28. Ataei B, Nokhodian Z, Javadi AA, et al. Hepatitis E virus in Isfahan Province: a population-based study. Int J Infect Dis 2009; 13:67-71.
29. Bawazir AA, Hart CA, Sallam TA, Parry CM, Beeching NJ, Cuevas LE. Seroepidemiology of hepatitis A and hepatitis E viruses in Aden, Yemen. Trans Royal Soc Trop Med Hyg 2010; 104:801-5.
30. Davaalkham D, Enkhoyun T, Takahashi M, Nakamura Y, Okamoto H. Hepatitis A and E virus infections among children in Mongolia. Am J Trop Med Hyg 2009; 81:248-51.
31. Tsatsralt-Od B, Takahashi M, Endo K, Agiimaa D, Buyankhuu O, Okamoto H. Comparison of hepatitis A and E virus infections among healthy children in Mongolia: evidence for infection with a subgenotype IA HAV in children. J Med Virol 2007; 79:18-25. (Pubitemid 44902049)
32. Achwan WA, Muttaqin Z, Zakaria E, et al. Epidemiology of hepatitis B, C, and E viruses and human immunode ficiency virus infections in Tahuna, Sangihe-Talaud Archipelago, Indonesia. Intervirol 2007; 50:408-11. (Pubitemid 351309881)
33. Yun H, Lee H-J, Cheon D, et al. Seroprevalence of hepatitis A and E viruses based on the Third Korea National Health and Nutrition Survey in Korea. Public Health Res Perspect 2011; 2:46-50.
34. Dong C, Dai X, Shao J-S, Hu K, Meng J-H. Identification of genetic diversity of hepatitis E virus (HEV) and determination of the seroprevalence of HEV in eastern China. Arch Virol 2007; 152:739-46. (Pubitemid 46452221)
35. Lu J, Zhou Y, Lin X, et al. General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study. PLoS One 2009; 4:e8467.
36. Martinson FE, Marfo VY, DeGraaf J. Hepatitis E virus seroprevalence in children living in rural Ghana. West Afr J Med 1999; 18:76-9.
37. Hodges M, Sanders E, Aitken C. Seroprevalence of hepatitis markers; HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med 1998; 17:36-7.
38. Fix AD, Abdel-Hamid M, Purcell R, et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg 2000; 62:519-23. (Pubitemid 32164763)
39. Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009; 44:272-6.
40. Langer BCA, Frosner GG, von Brunn A. Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits inWest Greenland. J Viral Hepat 1997; 4:339-49. (Pubitemid 127733424)
41. Bernal MC, Leyva A, Garcia E, et al. Seroepidemiological study of hepatitis E virus in different population groups. Eur J Clin Microbiol Infect Dis 1995; 14:954-8.
42. Buti M, Plans P, Dominguez A, et al. Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol 2008; 15:732-34. (Pubitemid 351967042)
43. Sidal M, Unuvar E, Oguz F, Cihan C, Onel D, Badur S. Age-specific seropepidemiology of hepatitis A, B and E infections among children in Istanbul, Turkey. Eur J Epidemiol 2001; 17:141-4. (Pubitemid 32900040)
44. Atabek ME, Fýndýk D, Gulyuz A, Erkul I. Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey. Health Policy 2004; 67:265-9. (Pubitemid 38221516)
45. Maral I, Budakoglu II, Ceyhan MN, Atak A, Bumin MA. Hepatitis E virus seroepidemiology and its change during 1 year in primary school students in Ankara, Turkey. Clin Microbiol Infect 2010; 16:831-5.
46. Alvarez-Muñoz MT, Torres J, Damasio L, Gómez A, Tapia-Conyer R, Muñoz O. Seroepidemiology of hepatitis E virus infection in Mexican subjects 1 to 29 years of age. Arch Med Res 1999; 30:251-4. (Pubitemid 29352177)
47. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley E, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200:48-56.
48. Pujol FH, Favorov MO, Marcano T, et al. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol 1994; 42:234-6. (Pubitemid 24131388)
49. Rey JA, Findor JA, Daruich JR, et al. Prevalence of IgG anti-HEV in Buenos Aires, a nonendemic area for hepatitis E. J Travel Med 1997; 4:100-1. (Pubitemid 27287256)
50. Bartoloni A, Bartalesi F, Roselli M, et al. Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia. Trop Med Int Health 1999; 4:596-601. (Pubitemid 29470215)
51. Dell'Amico MC, Cavallo A, Gonzales JL, et al. Hepatitis E virus genotype 3 in humans and swine, Bolivia. Emerg Infect Dis 2011; 17:1488-90.
52. Villalba MCM, Guan M, Pérez A, et al. Seroprevalence of antibodies to hepatitis E virus in two large communities in Havana, Cuba. Trans Royal Soc Trop Med Hyg 2010; 104:772-6.
53. Murhekar MV, Sehgal SC, Murhekar KM, Padbhidri SB, Chitambar SD, Arankalle VA. Changing scenario of hepatitis A virus and hepatitis E virus exposure among the primitive tribes of Andaman and Nicobar Islands, India over the 10-year period 1989 - 99. J Viral Hepat 2002; 9:315-21. (Pubitemid 36002468)
54. Hyams KC, McCarthy MC, Kaur M, et al. Acute sporadic hepatitis E in children living in Cairo, Egypt. J Med Virol 1992; 37:274-7.
55. El-Zimaity DMT, Hyams KC, Imam IZE, et al. Acute sporadic hepatitis E in an Egyptian pediatric population. Am J Trop Med Hyg 1993; 48:372-6. (Pubitemid 23115322)
56. Lay LAR, Quintana A, Villalba MCM, et al. Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998-2003. J Med Virol 2008; 80:98-802.
57. Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. Nat Med J India 2006; 19:203-17. (Pubitemid 44596410)
58. Arankalle VA, Chadha MS, Mehendale SM, Tungatkar SP. Epidemic hepatitis E: Serological evidence for lack of intrafamilial spread. Indian J Gastroenterol 2000; 19:24-8.
59. Viswanathan R, Sidhu AS. Infectious hepatitis: clinical findings. Ind J Med Res 1957; 45(suppl):49-58.
60. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980; 80:818-24. (Pubitemid 10114091)
61. Thapa R, Biswas B, Mallick D, Ghosh A. Acute pancreatitis-complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency. Clin Pediatr (Phila) 2009; 48:199-201.
62. Thapa R, Mallick D, Ghosh A. Childhood hepatitis E infection complicated by acute immune thrombocytopenia. J Pediatr Hematol Oncol 2009; 31:151.
63. Thapa R, Biswas B, Mallick D. Henoch-Schonlein purpura triggered by acute hepatitis E virus infection. J Emerg Med 2010; 39:218-9.
64. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatol 1996; 23:1448-55. (Pubitemid 26181228)
65. Jagadisan B, Srivastava A, Yachha SK, Poddar U. Acute on chronic liver disease in children from the developing world: recognition and prognosis. J Pediatr Gastroenterol Nutr 2012; 54:77-82.
66. Arora NK, Nanda SK, Gulati S, et al. Acute viral hepatitis types E, A and B singly and in combination in acute liver failure in children in North India. J Med Virol 1996; 48:215-21. (Pubitemid 26101544)
67. Agrawal V, Goel A, Rawat A, Naik S, Aggarwal R. Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol 2012; 55:22-7.
68. Ramachandran J, Ramakrishna B, Eapen CE, et al. Subacute hepatic failure due to hepatitis E. J Gastroenterol Hepatol 2008; 23:879-82. (Pubitemid 351806571)
69. Malcolm P, Dalton H, Hussaini HS, Mathew J. The histopathology of acute autochthonous hepatitis E infection. Histopathology 2007; 51:190-4. (Pubitemid 47083999)
70. Hoerning A, Hegen B, Wingen A-M, et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients - a single- center experience. Pediatr Transplant 2012; 16:742-7.
71. Halac U, Beland K, Lapierre P, et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012; 61:597-603.
72. Aggarwal R. Clinical presentation of hepatitis E. Virus Res 2011; 161:15-22.
73. Halac U, Beland K, Lapierre P, et al. Cirrhosis due to chronic hepatitis E in a child post-bone marrow transplant. J Pediatr 2012; 160:871-4.
74. Begum N, Polipalli SK, Husain SA, Kumar A, Kar P. Duration of hepatitis E viremia in pregnancy. Int J Gynecol Obstet 2010; 108: 207-10.
75. Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat 2009; 16:519-23.
76. Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Intl J Gynaecol Obstet 2004; 85:240-4. (Pubitemid 38622553)
77. Dahiya M, Kumar A, Kar P, Gupta RK, Kumar A. Acute viral hepatitis in third trimester of pregnancy. Indian J Gastroenterol 2005; 24:128-9. (Pubitemid 40980047)
78. Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to- child transmission of hepatitis E virus infection. Indian J Pediatr 2003; 70:37-9. (Pubitemid 36249584)
79. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 315:1025-6.
80. Kumar RM, Udumann S, Rana S, Kochiyil JK, Usmani A, Thomas L. Seroprevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001; 100:9-15. (Pubitemid 33124264)
81. Clayson ET, Myint KSA, Snitbhan R, et al. Viremia, fecal shedding and IgG and IgM responses in patients with hepatitis E. J Infect Dis 1995; 172:927-33.
82. Chandra NS, Sharma A, Malhotra B, Raj RR. Dynamics of HEV viremia, fecal shedding and its relationship with transaminases and antibody responses in patients with sporadic acute hepatitis E. Virol J 2010; 7:213.
83. Koshy A, Grover S, Hyams KC, et al. Short-term IgM and IgG antibody responses to hepatitis E virus infection. Scand J Infect Dis 1996; 28:439-41. (Pubitemid 26393582)
84. Goldsmith R, Yarbough PO, Reyes GR, et al. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 1992; 339:328-31.
85. Favorov MO, Fields HA, Purdy MA, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992; 36:246-50.
86. Khudyakov Y, Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res 2011; 161:84-92.
87. Zaki ME, Zagloul MHE, El-Sayed O. Acute sporadic hepatitis E in children: diagnostic relevance of specific immunoglobulin M and immunoglobulin G compared with nested reverse transcriptase PCR. FEMS Immunol Med Microbiol 2006; 48:16-20. (Pubitemid 44379215)
88. Zhang JZ, Im SW, Lau SH, et al. Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non- A, -B, and -C acute hepatitis. J Med Virol 2002; 66:40-8. (Pubitemid 34183716)
89. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013; 207:497-500.
90. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82:799-805.
91. Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-α for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50:e30-3.
92. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010; 139:1612-8.
93. Kamili S. Toward the development of a hepatitis E vaccine. Virus Res 2011; 161:93-100.
94. Shresta MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895-903. (Pubitemid 46339908)
95. Zhu F-C, Zhang J, Zhang X-F, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, doubleblind placebo-controlled, phase 3 trial. Lancet 2010; 376:895-902.
96. Park SB. Hepatitis E vaccine debuts. Nature 2012; 491:21-2.